This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Pat Phillips

JAMA. 1999;282:1117-1118.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Vancouver, BC—Deep brain stimulation and cell transplantation have fired interest in the surgical treatment of patients with Parkinson disease (PD), particularly those with more advanced, severe disease.

One factor pushing the resurgence of surgical treatment is the limited success of medical therapy with levodopa, said C. Warren Olanow, MD, chair of neurology at Mount Sinai School of Medicine in New York City, who spoke on "surgery from a physician's point of view" at the 13th International Congress on Parkinson Disease here in July.

Other factors are safer and more accurate surgical techniques, improvements in intraoperative microrecordings, and advances in neuroimaging, all of which combine to allow surgeons to reach their targets with greater accuracy and less likelihood of adverse effects.

DEEP BRAIN STIMULATION

At specialized centers in Europe and North America, high-frequency deep brain stimulation of three different targets in the brain has been the focus of . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?
Clark
J Law Med Ethics 2002;30:58-68.